Acute cholecystitis resident survival guide: Difference between revisions
Rim Halaby (talk | contribs) |
|||
(18 intermediate revisions by 2 users not shown) | |||
Line 2: | Line 2: | ||
{{CMG}}; {{AE}} {{VR}} | {{CMG}}; {{AE}} {{VR}} | ||
== | ==Overview== | ||
[[Cholecystitis]] is the inflammation of the gallbladder.<br> | [[Cholecystitis]] is the inflammation of the gallbladder.<br> | ||
Line 33: | Line 33: | ||
{{familytree/start |summary=Cholecystitis}} | {{familytree/start |summary=Cholecystitis}} | ||
{{familytree | | | | | | | A01 | | | | | | | |A01=<div style="float: left; text-align: left; | {{familytree | | | | | | | A01 | | | | | | | |A01=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Characterize the symptoms:'''<br><br> | ||
'''Symptoms suggestive of calculous or acalculous cholecystitis:'''<br>❑ Acute RUQ or epigastric pain<br> | '''Symptoms suggestive of calculous or acalculous cholecystitis:'''<br>❑ Acute RUQ or epigastric pain<br> | ||
:❑ Sharp, severe and steady | :❑ Sharp, severe and steady | ||
Line 47: | Line 46: | ||
::❑ [[Anorexia]] | ::❑ [[Anorexia]] | ||
::❑ Mass in the RUQ | ::❑ Mass in the RUQ | ||
::❑ | ::❑ Symptoms suggestive of [[Sepsis history and symptoms|sepsis]] | ||
::❑ | ::❑ Symptoms suggestive of [[Mirizzi's syndrome|common hepatic duct obstruction]] | ||
:::❑ RUQ pain with fever & [[jaundice]] | :::❑ RUQ pain with fever & [[jaundice]] | ||
::❑ | ::❑ Symptoms suggestive of [[gallstone ileus]] | ||
:::❑ Transient abdominal pain with nausea & vomiting | :::❑ Transient abdominal pain with nausea & vomiting | ||
:::❑ [[Hematemesis]] | :::❑ [[Hematemesis]] | ||
'''OR''' <br> | |||
''' | '''Atypical symptoms suggestive of acalculous cholecystitis:'''<br> | ||
❑ Acute vague abdominal pain | ❑ Acute vague abdominal pain | ||
:❑ Associated with | :❑ Associated with | ||
Line 61: | Line 60: | ||
::❑ Fever</div>}} | ::❑ Fever</div>}} | ||
{{familytree | | | | | | | |!| | | | | | | | |}} | {{familytree | | | | | | | |!| | | | | | | | |}} | ||
{{familytree | | | | | | | B01 | | | | | | | |B01=<div style="float: left; text-align: left; | {{familytree | | | | | | | B01 | | | | | | | |B01=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Examine the patient:'''<BR>❑ [[Fever]]<BR>❑ Jaundice<BR>❑ Dehydration<BR>❑ Tachycardia<BR>❑ RUQ mass<BR>❑ [[Abdominal guarding]]<BR>❑ [[Murphy's sign]]<BR>❑ Abdominal crepitations<BR>❑ Abdominal tenderness<BR>❑ Reduced bowel sounds<BR>❑ Increased bowel sounds<BR>❑ [[Abdominal distension]]<BR>❑ [[Sepsis physical examination|Signs of sepsis]]</div>}} | ||
{{familytree | | | | | | | |!| | | | | | | | |}} | {{familytree | | | | | | | |!| | | | | | | | |}} | ||
{{familytree | | | | | | | C01 | | | | | | | |C01=<div style="float: left; text-align: left; | {{familytree | | | | | | | C01 | | | | | | | |C01=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Consider alternative diagnoses:'''<BR>❑ [[Acute hepatitis]]<BR>❑ [[Acute pancreatitis]]<BR>❑ [[Appendicitis]]<BR>❑ [[Biliary colic]]<BR>❑ [[Angina|Cardiac ischemia]]<BR>❑ Diseases of the right kidney<BR>❑ [[Fitz-Hugh-Curtis syndrome]]<BR>❑ Functional gallbladder disorder<BR>❑ [[Irritable bowel disease]]<BR>❑ [[Nonulcer dyspepsia]]<BR>❑ [[Peptic ulcer disease]]<BR>❑ Perforated viscus<BR>❑ [[Pneumonia|Right-sided pneumonia]]<BR>❑ Sphincter of Oddi dysfunction<BR>❑ [[Subphrenic abscess|Subhepatic]] or intraabdominal abscess</div>}} | ||
'''Consider alternative diagnoses:'''<BR>❑ [[Acute hepatitis]]<BR>❑ [[Acute pancreatitis]]<BR>❑ [[Appendicitis]]<BR>❑ [[Biliary colic]]<BR>❑ [[Angina|Cardiac ischemia]]<BR>❑ Diseases of the right kidney<BR>❑ [[Fitz-Hugh-Curtis syndrome]]<BR>❑ Functional gallbladder disorder<BR>❑ [[Irritable bowel disease]]<BR>❑ [[Nonulcer dyspepsia]]<BR>❑ [[Peptic ulcer disease]]<BR>❑ Perforated viscus<BR>❑ [[Pneumonia|Right-sided pneumonia]]<BR>❑ Sphincter of Oddi dysfunction<BR>❑ [[Subphrenic abscess|Subhepatic]] or intraabdominal abscess</div>}} | |||
{{familytree | | | | | | | |!| | | | | | | | |}} | {{familytree | | | | | | | |!| | | | | | | | |}} | ||
{{familytree | | | | | | | D01 | | | | | | | |D01=<div style="float: left; text-align: left; | {{familytree | | | | | | | D01 | | | | | | | |D01=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Order laboratory tests:'''<br>❑ [[CBC]]<br>❑ BMP<br>❑ [[CRP]]<br>❑ Total [[bilirubin]]<br>❑ Direct [[bilirubin]]<br>❑ [[Albumin]]<br>❑ [[AST]]<br>❑ [[ALT]]<br>❑ [[Alkaline phosphatase]]<br>❑ [[GGT]]<br>❑ [[Amylase]]<br>❑ [[Lipase]] | ||
---- | ---- | ||
❑ '''Order urgent transabdominal USG (TAUSG)'''</div>}} | ❑ '''Order urgent transabdominal USG (TAUSG)'''</div>}} | ||
{{familytree | | |,|-|-|-|-|+|-|-|-|-|.| | |}} | {{familytree | | |,|-|-|-|-|+|-|-|-|-|.| | |}} | ||
{{familytree | | E01 | | | E02 | | E03 | |E01= | {{familytree | | E01 | | | E02 | | E03 | |E01='''Gallbladder stones with gallbladder edema'''|E02='''Gallbladder stones without gallbladder edema, or''' <br> '''Gallbladder edema without gallbladder stones'''|E03= '''No gallbladder stones and no gallbladder edema'''}} | ||
{{familytree | | |!| | | | |!| | | |!| | |}} | {{familytree | | |!| | | | |!| | | |!| | |}} | ||
{{familytree | | |!| | | | F01 | | F02 | |F01=HIDA scan|F02=[[Abdominal pain resident survival guide|Consider evaluation for alternate diagnosis of abdominal pain]]}} | {{familytree | | |!| | | | F01 | | F02 | |F01=❑ HIDA scan|F02=❑ [[Abdominal pain resident survival guide|Consider evaluation for alternate diagnosis of abdominal pain]]}} | ||
{{familytree | | |!| | |,|-|^|-|.| | | |}} | {{familytree | | |!| | |,|-|^|-|.| | | |}} | ||
{{familytree | | |!| | G02 | | G03 | | |G02= | {{familytree | | |!| | G02 | | G03 | | |G02=Gallbladder opacity not visualized|G03=Gallbladder opacity visualized}} | ||
{{familytree | | |!| |!| | | | |!| | | | }} | {{familytree | | |!| |!| | | | |!| | | | }} | ||
{{familytree | | |!| |!| | | | H01 | | | H01= CT abdomen}} | {{familytree | | |!| |!| | | | H01 | | | H01= ❑ [[CT]] abdomen}} | ||
{{familytree | | |!| |!| | | | |!| | | | }} | {{familytree | | |!| |!| | | | |!| | | | }} | ||
{{familytree | | | I01 | | | | I02 | | | I01= <div style="float: left; text-align: left; | {{familytree | | | I01 | | | | I02 | | | I01= <div style="float: left; text-align: left; width: 25em; padding:1em;">'''Consider the [[Cholecystitis overview#Diagnostic Criteria|diagnostic criteria]] of acute calculous cholecystitis''':<ref name="Takada-2007">{{Cite journal | last1 = Takada | first1 = T. | last2 = Kawarada | first2 = Y. | last3 = Nimura | first3 = Y. | last4 = Yoshida | first4 = M. | last5 = Mayumi | first5 = T. | last6 = Sekimoto | first6 = M. | last7 = Miura | first7 = F. | last8 = Wada | first8 = K. | last9 = Hirota | first9 = M. | title = Background: Tokyo Guidelines for the management of acute cholangitis and cholecystitis. | journal = J Hepatobiliary Pancreat Surg | volume = 14 | issue = 1 | pages = 1-10 | month = | year = 2007 | doi = 10.1007/s00534-006-1150-0 | PMID = 17252291 }}</ref><ref name="Hirota-2007">{{Cite journal | last1 = Hirota | first1 = M. | last2 = Takada | first2 = T. | last3 = Kawarada | first3 = Y. | last4 = Nimura | first4 = Y. | last5 = Miura | first5 = F. | last6 = Hirata | first6 = K. | last7 = Mayumi | first7 = T. | last8 = Yoshida | first8 = M. | last9 = Strasberg | first9 = S. | title = Diagnostic criteria and severity assessment of acute cholecystitis: Tokyo Guidelines. | journal = J Hepatobiliary Pancreat Surg | volume = 14 | issue = 1 | pages = 78-82 | month = | year = 2007 | doi = 10.1007/s00534-006-1159-4 | PMID = 17252300 }}</ref><br>❑ Local symptoms & signs | ||
:❑ [[Murphy’s sign]] | :❑ [[Murphy’s sign]] | ||
:❑ Pain or tenderness in RUQ | :❑ Pain or tenderness in RUQ | ||
Line 89: | Line 86: | ||
❑ Imaging findings | ❑ Imaging findings | ||
:❑ [[Cholecystitis ultrasound#Calculous Cholecystitis|TAUSG]] | :❑ [[Cholecystitis ultrasound#Calculous Cholecystitis|TAUSG]] | ||
:❑ [[Cholecystitis other diagnostic studies#Calculous Cholecystitis|HIDA scan]]</div>| I02= <div style="float: left; text-align: left; | :❑ [[Cholecystitis other diagnostic studies#Calculous Cholecystitis|HIDA scan]]</div>| I02= <div style="float: left; text-align: left; width: 25em; padding:1em;">'''Consider the diagnostic criteria of acute acalculous cholecystitis:'''<ref name="Huffman-2010">{{Cite journal | last1 = Huffman | first1 = JL. | last2 = Schenker | first2 = S. | title = Acute acalculous cholecystitis: a review. | journal = Clin Gastroenterol Hepatol | volume = 8 | issue = 1 | pages = 15-22 | month = Jan | year = 2010 | doi = 10.1016/j.cgh.2009.08.034 | PMID = 19747982 }}</ref><BR>❑ Acute abdominal pain<BR>❑ Fever<BR>❑ Leukocytosis<BR>❑ Abnormal liver function tets<BR>❑ Imaging based criteria | ||
:❑ [[Cholecystitis ultrasound#Imaging Criteria for Acalculous Cholecystitis|TAUSG based]] | :❑ [[Cholecystitis ultrasound#Imaging Criteria for Acalculous Cholecystitis|TAUSG based criteria]] | ||
:❑ [[Cholecystitis other diagnostic studies#Imaging Criteria for Acalculous Cholecystitis|HIDA scan based]] | :❑ [[Cholecystitis other diagnostic studies#Imaging Criteria for Acalculous Cholecystitis|HIDA scan based criteria]] | ||
:❑ [[Cholecystitis CT#Imaging Criteria for Acalculous Cholecystitis|CT based criteria]]</div>}} | :❑ [[Cholecystitis CT#Imaging Criteria for Acalculous Cholecystitis|CT based criteria]]</div>}} | ||
{{familytree/end}} | {{familytree/end}} | ||
'''ALT:''' Alanine aminotransferase; '''AST:''' Aspartate aminotransferase; '''BMP:''' Basic metabolic | <span style="font-size:85%"> '''ALT:''' Alanine aminotransferase; '''AST:''' Aspartate aminotransferase; '''BMP:''' Basic metabolic panel; '''CBC:''' Complete blood count; '''CRP:''' C-reactive protein; '''CT:''' Computed tomography; '''GGT:''' Gamma-glutamyl transpeptidase; '''HIDA scan:''' Hepatobiliary iminodiacetic acid scan; '''RUQ:''' Right upper quadrant</span> | ||
<br> | |||
<br> | |||
===Treatment Approach=== | ===Treatment Approach=== | ||
Line 119: | Line 118: | ||
{{familytree | | | F01 | | F02 | | F03 | | F01= <div style="float: left; text-align: left; width: 25em; padding:1em;">'''Without complications & non high risk surgical candidates:'''<br>❑ Immediate cholecystectomy + blood C&S ± bile C&S </div>| F02= <div style="float: left; text-align: left; width: 25em; padding:1em;">'''Without complications & high risk surgical candidates:'''<br>❑ Immediate biliary drainage + blood C&S ± bile C&S </div>| F03= <div style="float: left; text-align: left; width: 25em; padding:1em;">'''With complications:'''<br>❑ Emergency cholecystectomy + blood C&S ± bile C&S <br> ❑ Consider appropriate surgeries for [[Gallstone ileus#Treatment|gallstone ileus]] & [[Mirizzi's syndrome surgery|Mirizzi syndrome]]</div>}} | {{familytree | | | F01 | | F02 | | F03 | | F01= <div style="float: left; text-align: left; width: 25em; padding:1em;">'''Without complications & non high risk surgical candidates:'''<br>❑ Immediate cholecystectomy + blood C&S ± bile C&S </div>| F02= <div style="float: left; text-align: left; width: 25em; padding:1em;">'''Without complications & high risk surgical candidates:'''<br>❑ Immediate biliary drainage + blood C&S ± bile C&S </div>| F03= <div style="float: left; text-align: left; width: 25em; padding:1em;">'''With complications:'''<br>❑ Emergency cholecystectomy + blood C&S ± bile C&S <br> ❑ Consider appropriate surgeries for [[Gallstone ileus#Treatment|gallstone ileus]] & [[Mirizzi's syndrome surgery|Mirizzi syndrome]]</div>}} | ||
{{familytree/end}} | {{familytree/end}} | ||
'''CNS:''' Central nervous system; '''C&S:''' Culture & sensitivity; '''GBS:''' Gallbladder stone; '''IV:''' Intravenous; '''IVF:''' Intravenous fluids; '''NPO:''' Nil per oral | |||
<span style="font-size:85%">'''CNS:''' Central nervous system; '''C&S:''' Culture & sensitivity; '''GBS:''' Gallbladder stone; '''IV:''' Intravenous; '''IVF:''' Intravenous fluids; '''NPO:''' Nil per oral </span> | |||
<br> | |||
====Acute Acalculous Cholecystitis==== | ====Acute Acalculous Cholecystitis==== | ||
Line 133: | Line 134: | ||
==Do's== | ==Do's== | ||
* | * Administer antibiotics if infection is suspected on the basis of laboratory and clinical findings (>12,500 white cells/mm <sup>3</sup> or temperature >38.5°C) and radiographic findings (e.g., air in the gallbladder or gallbladder wall) as per the Infectious Diseases Society of America recommendation.<ref name="Solomkin-2003">{{Cite journal | last1 = Solomkin | first1 = JS. | last2 = Mazuski | first2 = JE. | last3 = Baron | first3 = EJ. | last4 = Sawyer | first4 = RG. | last5 = Nathens | first5 = AB. | last6 = DiPiro | first6 = JT. | last7 = Buchman | first7 = T. | last8 = Dellinger | first8 = EP. | last9 = Jernigan | first9 = J. | title = Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. | journal = Clin Infect Dis | volume = 37 | issue = 8 | pages = 997-1005 | month = Oct | year = 2003 | doi = 10.1086/378702 | PMID = 14523762 }}</ref> | ||
* | * Administer prophylactic antibiotics before surgery among high risk patients characterized by age >60 years, presence of [[diabetes]], acute colic within 30 days of operation, [[jaundice]], [[acute cholecystitis]], or [[cholangitis]] ([[SAGES system classification scheme|Level I, Grade B]]). | ||
** Limit the prophylactic antibiotics to a single preoperative dose given within 1 hour of skin incision ([[SAGES system classification scheme|Level II, Grade A]]). | |||
** | * Early [[laparoscopic cholecystectomy]] is the preferred approach and should be done in patients with acute cholecystitis ([[SAGES system classification scheme|Level II, Grade B]]). | ||
*Early [[laparoscopic cholecystectomy]] is the preferred approach and should be done in patients with acute cholecystitis ([[SAGES system classification scheme|Level II, Grade B]]). | * Radiographically guided percutaneous cholecystostomy is the effective method of biliary drainage and should be done in critically ill patients with acute cholecystitis, until the patient recovers sufficiently to undergo cholecystectomy ([[SAGES system classification scheme|Level II, Grade B]]). | ||
*Radiographically guided percutaneous cholecystostomy is the effective method of biliary drainage and should be done in critically ill patients with acute cholecystitis, until the patient recovers sufficiently to undergo cholecystectomy ([[SAGES system classification scheme|Level II, Grade B]]). | * Determine the time to discharge after surgery for patients with acute cholecystitis on an individual basis ([[SAGES system classification scheme|Level III, Grade A]]). | ||
* | * Consider evaluating the patient for [[choledocholithiasis]] and [[cholangitis]] if the patient has significantly elevated total bilirubin, alkaline phosphatase, ALT, AST and/or GGT. | ||
==Dont's== | ==Dont's== | ||
* | * Do not administer antibiotics among low-risk patients undergoing laparoscopic cholecystectomy ([[SAGES system classification scheme|Level I, Grade A]]). | ||
* | * Do not place a drain after elective laparoscopic cholecystectomy because the use of drains may increase complication rates. ([[SAGES system classification scheme|Level I, Grade A]]). | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Latest revision as of 14:46, 12 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vendhan Ramanujam M.B.B.S [2]
Overview
Cholecystitis is the inflammation of the gallbladder.
Shown below is a table summarizing the different key terms used to refer to cholecystitis.
Terms | Definitions |
---|---|
Acute cholecystitis | Acute cholecystitis is an acute inflammatory disease of the gallbladder, most often attributable to gallstones.[1][2] |
Acute calculous cholecystitis | Acute calculous cholecystitis is an acute inflammatory disease of the gallbladder in the presence of cholelithiasis.[1] The Tokyo guidelines are used in the diagnosis of acute calculous cholecystitis.[3][4] |
Acute acalculous cholecystitis | Acute acalculous cholecystitis is an acute necroinflammatory disease of the gallbladder in the absence of cholelithiasis and has a multifactorial pathogenesis.[5] |
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
Management
Diagnostic Approach
Shown below is an algorithm depicting the diagnostic approach of acute cholecystitis according to the Society for Surgery of the Alimentary Tract (SSAT),[7] the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES),[8] the Tokyo guidelines for management of cholecystitis,[9] and review of data from multiple studies on acalculous cholecystitis.[5]
Characterize the symptoms: Symptoms suggestive of calculous or acalculous cholecystitis:
OR
| |||||||||||||||||||||||||||||||||
Examine the patient: ❑ Fever ❑ Jaundice ❑ Dehydration ❑ Tachycardia ❑ RUQ mass ❑ Abdominal guarding ❑ Murphy's sign ❑ Abdominal crepitations ❑ Abdominal tenderness ❑ Reduced bowel sounds ❑ Increased bowel sounds ❑ Abdominal distension ❑ Signs of sepsis | |||||||||||||||||||||||||||||||||
Consider alternative diagnoses: ❑ Acute hepatitis ❑ Acute pancreatitis ❑ Appendicitis ❑ Biliary colic ❑ Cardiac ischemia ❑ Diseases of the right kidney ❑ Fitz-Hugh-Curtis syndrome ❑ Functional gallbladder disorder ❑ Irritable bowel disease ❑ Nonulcer dyspepsia ❑ Peptic ulcer disease ❑ Perforated viscus ❑ Right-sided pneumonia ❑ Sphincter of Oddi dysfunction ❑ Subhepatic or intraabdominal abscess | |||||||||||||||||||||||||||||||||
Gallbladder stones with gallbladder edema | Gallbladder stones without gallbladder edema, or Gallbladder edema without gallbladder stones | No gallbladder stones and no gallbladder edema | |||||||||||||||||||||||||||||||
❑ HIDA scan | ❑ Consider evaluation for alternate diagnosis of abdominal pain | ||||||||||||||||||||||||||||||||
Gallbladder opacity not visualized | Gallbladder opacity visualized | ||||||||||||||||||||||||||||||||
❑ CT abdomen | |||||||||||||||||||||||||||||||||
Consider the diagnostic criteria of acute calculous cholecystitis:[3][4] ❑ Local symptoms & signs
❑ Systemic signs
❑ Imaging findings | Consider the diagnostic criteria of acute acalculous cholecystitis:[5] ❑ Acute abdominal pain ❑ Fever ❑ Leukocytosis ❑ Abnormal liver function tets ❑ Imaging based criteria | ||||||||||||||||||||||||||||||||
ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; BMP: Basic metabolic panel; CBC: Complete blood count; CRP: C-reactive protein; CT: Computed tomography; GGT: Gamma-glutamyl transpeptidase; HIDA scan: Hepatobiliary iminodiacetic acid scan; RUQ: Right upper quadrant
Treatment Approach
Shown below are algorithms depicting the treatment approach of acute calculous cholecystitis and acute acalculous cholecystitis according to the Society for Surgery of the Alimentary Tract (SSAT),[7] the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES),[8] the Tokyo guidelines for management of cholecystitis,[9] and review of data from multiple studies on acalculous cholecystitis.[5]
Acute Calculous Cholecystitis
Acute calculous cholecystitis | |||||||||||||||||||||||||||||||||
❑ Hospital admission ❑ NPO ❑ IVF & correct electrolyte abnormalities ❑ Empiric IV antibiotics[10]
or
or
| |||||||||||||||||||||||||||||||||
Grade 1 (Mild) | Grade 2 (Moderate) | Grade 3 (Severe) | |||||||||||||||||||||||||||||||
❑ Cholecystectomy within 72 hours | ❑ Assess for complications and surgical risk | ❑ Emergency biliary drainage + blood C&S ± bile C&S ❑ Cholecystectomy after 3 months if GBS found during biliary drainage | |||||||||||||||||||||||||||||||
Without complications & non high risk surgical candidates: ❑ Immediate cholecystectomy + blood C&S ± bile C&S | Without complications & high risk surgical candidates: ❑ Immediate biliary drainage + blood C&S ± bile C&S | With complications: ❑ Emergency cholecystectomy + blood C&S ± bile C&S ❑ Consider appropriate surgeries for gallstone ileus & Mirizzi syndrome | |||||||||||||||||||||||||||||||
CNS: Central nervous system; C&S: Culture & sensitivity; GBS: Gallbladder stone; IV: Intravenous; IVF: Intravenous fluids; NPO: Nil per oral
Acute Acalculous Cholecystitis
Acute acalculous cholecystitis | |||||||||||||||
❑ Immediate biliary drainage | |||||||||||||||
❑ Patient improves | ❑ Patient does not improve | ||||||||||||||
❑ Urgent cholecystectomy | |||||||||||||||
Do's
- Administer antibiotics if infection is suspected on the basis of laboratory and clinical findings (>12,500 white cells/mm 3 or temperature >38.5°C) and radiographic findings (e.g., air in the gallbladder or gallbladder wall) as per the Infectious Diseases Society of America recommendation.[10]
- Administer prophylactic antibiotics before surgery among high risk patients characterized by age >60 years, presence of diabetes, acute colic within 30 days of operation, jaundice, acute cholecystitis, or cholangitis (Level I, Grade B).
- Limit the prophylactic antibiotics to a single preoperative dose given within 1 hour of skin incision (Level II, Grade A).
- Early laparoscopic cholecystectomy is the preferred approach and should be done in patients with acute cholecystitis (Level II, Grade B).
- Radiographically guided percutaneous cholecystostomy is the effective method of biliary drainage and should be done in critically ill patients with acute cholecystitis, until the patient recovers sufficiently to undergo cholecystectomy (Level II, Grade B).
- Determine the time to discharge after surgery for patients with acute cholecystitis on an individual basis (Level III, Grade A).
- Consider evaluating the patient for choledocholithiasis and cholangitis if the patient has significantly elevated total bilirubin, alkaline phosphatase, ALT, AST and/or GGT.
Dont's
- Do not administer antibiotics among low-risk patients undergoing laparoscopic cholecystectomy (Level I, Grade A).
- Do not place a drain after elective laparoscopic cholecystectomy because the use of drains may increase complication rates. (Level I, Grade A).
References
- ↑ 1.0 1.1 Strasberg, SM. (2008). "Clinical practice. Acute calculous cholecystitis". N Engl J Med. 358 (26): 2804–11. doi:10.1056/NEJMcp0800929. PMID 18579815. Unknown parameter
|month=
ignored (help) - ↑ Reiss, R.; Deutsch, AA. (1993). "State of the art in the diagnosis and management of acute cholecystitis". Dig Dis. 11 (1): 55–64. PMID 8443956.
- ↑ 3.0 3.1 Takada, T.; Kawarada, Y.; Nimura, Y.; Yoshida, M.; Mayumi, T.; Sekimoto, M.; Miura, F.; Wada, K.; Hirota, M. (2007). "Background: Tokyo Guidelines for the management of acute cholangitis and cholecystitis". J Hepatobiliary Pancreat Surg. 14 (1): 1–10. doi:10.1007/s00534-006-1150-0. PMID 17252291.
- ↑ 4.0 4.1 4.2 Hirota, M.; Takada, T.; Kawarada, Y.; Nimura, Y.; Miura, F.; Hirata, K.; Mayumi, T.; Yoshida, M.; Strasberg, S. (2007). "Diagnostic criteria and severity assessment of acute cholecystitis: Tokyo Guidelines". J Hepatobiliary Pancreat Surg. 14 (1): 78–82. doi:10.1007/s00534-006-1159-4. PMID 17252300.
- ↑ 5.0 5.1 5.2 5.3 Huffman, JL.; Schenker, S. (2010). "Acute acalculous cholecystitis: a review". Clin Gastroenterol Hepatol. 8 (1): 15–22. doi:10.1016/j.cgh.2009.08.034. PMID 19747982. Unknown parameter
|month=
ignored (help) - ↑ Kimura, Y.; Takada, T.; Kawarada, Y.; Nimura, Y.; Hirata, K.; Sekimoto, M.; Yoshida, M.; Mayumi, T.; Wada, K. (2007). "Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines". J Hepatobiliary Pancreat Surg. 14 (1): 15–26. doi:10.1007/s00534-006-1152-y. PMID 17252293.
- ↑ 7.0 7.1 Duncan, CB.; Riall, TS. (2012). "Evidence-based current surgical practice: calculous gallbladder disease". J Gastrointest Surg. 16 (11): 2011–25. doi:10.1007/s11605-012-2024-1. PMID 22986769. Unknown parameter
|month=
ignored (help) - ↑ 8.0 8.1 Overby, DW.; Apelgren, KN.; Richardson, W.; Fanelli, R.; Overby, DW.; Apelgren, KN.; Beghoff, KR.; Curcillo, P.; Awad, Z. (2010). "SAGES guidelines for the clinical application of laparoscopic biliary tract surgery". Surg Endosc. 24 (10): 2368–86. doi:10.1007/s00464-010-1268-7. PMID 20706739. Unknown parameter
|month=
ignored (help) - ↑ 9.0 9.1 Mayumi, T.; Someya, K.; Ootubo, H.; Takama, T.; Kido, T.; Kamezaki, F.; Yoshida, M.; Takada, T. (2013). "Progression of Tokyo Guidelines and Japanese Guidelines for management of acute cholangitis and cholecystitis". J UOEH. 35 (4): 249–57. PMID 24334691. Unknown parameter
|month=
ignored (help) - ↑ 10.0 10.1 Solomkin, JS.; Mazuski, JE.; Baron, EJ.; Sawyer, RG.; Nathens, AB.; DiPiro, JT.; Buchman, T.; Dellinger, EP.; Jernigan, J. (2003). "Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections". Clin Infect Dis. 37 (8): 997–1005. doi:10.1086/378702. PMID 14523762. Unknown parameter
|month=
ignored (help)